Sortase A-Mediated Farnesylation of Cdc42 In Vitro

Understanding how proteins regulate cell polarity remains a central challenge in cell biology. Cdc42, a member of the Rho-family GTPases, is known to be crucial for polarity establishment in yeast. However, studying Cdc42's interactions at the membrane has been limited by the difficulty of obtaining prenylated forms of the protein. While prenylation is essential for membrane binding, traditional methods for generating prenylated Cdc42 have been inefficient. Researchers have long sought a reliable way to produce functional prenylated Cdc42 in the lab. Prior studies have demonstrated that prenylation involves the addition of either farnesyl or geranylgeranyl groups to the C-terminus. Yet, the lack of a streamlined method has hindered progress in this area. This gap motivated the development of new biochemical techniques. The need for a scalable and efficient system to generate prenylated Cdc42 has been a persistent challenge. The current study addresses this limitation by introducing a novel strategy.

The aim of this work is to develop a practical method for farnesylation of Cdc42 in vitro. This is important because prenylated Cdc42 is necessary for studying its membrane interactions and polarity regulation. The specific problem addressed is the lack of an efficient way to produce prenylated Cdc42 for biochemical experiments. Traditional methods have been either too complex or insufficiently productive. The motivation for this study stems from the need to advance research on Cdc42's role in cell polarity. The proposed solution involves using sortase A, a well-characterized enzyme, to facilitate farnesylation. The study's focus is on optimizing this approach for reproducibility and scalability. The goal is to provide a reliable system for generating functional prenylated Cdc42.

The approach described here uses recombinant Cdc42 expressed in Escherichia coli. The Cdc42 construct includes a sortase A recognition motif, which is essential for the farnesylation reaction. The farnesylation is catalyzed by sortase A, which recognizes and cleaves the motif. After farnesylation, the protein is purified using a size exclusion strategy. This purification step is critical for isolating the modified Cdc42. The method is designed to be efficient and scalable for biochemical studies. The use of E. coli as an expression system allows for high yield of the protein. The sortase A recognition motif is strategically placed to ensure proper farnesylation. The final step involves verifying the functionality of the farnesylated Cdc42.

The farnesylated Cdc42 produced using this method retains its ability to bind membranes. This is a key finding, as membrane binding is essential for Cdc42's function. The protein also maintains GEF-regulatory GTPase activity, indicating functional integrity. The size exclusion purification successfully isolates the farnesylated form. The method achieves high efficiency in farnesylation, as demonstrated by the results. The farnesylated Cdc42 is suitable for further biophysical studies. The results confirm that the sortase A-based approach is effective for functional modification. The method provides a reliable alternative to traditional prenylation techniques.

The authors propose that this method offers a streamlined way to farnesylate Cdc42 in vitro. This approach is suitable for biochemical and biophysical investigations. The farnesylated Cdc42 retains both membrane binding and regulatory activity. The use of sortase A and a recognition motif is a key innovation in this study. The method is efficient and scalable for experimental use. The results support the authors' claim that this system is functional and reliable. The approach addresses a specific challenge in studying Cdc42's interactions. The findings suggest that this method can be used in future studies of Cdc42's role in polarity.